pruritus itching

Related by string. * : dermatitis acneiform pruritus erythema . uremic pruritus . urticaria pruritus . pruritus rash . rash pruritus nausea . pruritus . rash pruritus / Itching . itched . ITCH . ITCHING . Itch . ItCH : itch mite . irritation itching . itch mites . scalp itch . ocular itching associated . itching hives . ocular itching . vaginal itching . itching sneezing . itching redness * *

Related by context. Frequent words. (Click for all words.) 68 diarrhea nausea vomiting 66 hypercalcemia 65 ARCALYST 64 pruritus 64 inflammatory lesions 64 plus methotrexate 64 peripheral edema 63 erythema 63 lymphopenia 63 leukopenia 63 hypomagnesemia 63 mg QD 63 gout flares 63 orthostatic hypotension 63 certolizumab pegol 62 mg BID 62 bronchospasm 62 systemic absorption 62 nasopharyngitis 62 anakinra 62 hypoglycemic events 62 achieved statistical significance 62 Adverse reactions 62 abdominal pain diarrhea 62 nausea diarrhea 61 febrile neutropenia 61 severe renal impairment 61 thromboembolic events 61 discontinuations due 61 Gabapentin GR 61 tumor lysis syndrome 61 administered subcutaneously 60 stomatitis 60 PROMACTA 60 hypokalemia 60 seborrheic dermatitis 60 limiting toxicity 60 BROVANA 60 urticaria 60 ocular inflammation 60 adalimumab 60 adverse reactions observed 60 post herpetic neuralgia 60 Neutropenia 60 mucositis 60 nausea headache 60 redness swelling 60 DOXIL 60 Lamictal XR 59 mcg dose 59 Cimzia R 59 myelosuppression 59 telbivudine 59 vasomotor symptoms 59 abdominal bloating 59 photophobia 59 angioedema 59 topical steroid 59 Cimzia ® 59 tolvaptan 59 subcutaneous injections 59 events AEs 59 dacarbazine 58 amphotericin B 58 CIMZIA 58 TORISEL 58 endophthalmitis 58 treatment emergent adverse 58 chlorambucil 58 Navelbine 58 fumarate 58 μg kg 58 tamsulosin 58 long acting beta2 58 arthralgia 58 alvimopan 58 topical corticosteroids 58 PEG INTRON 58 mycophenolate mofetil 58 myalgia 58 headache nausea 58 Adverse events 58 PegIntron 58 LEXIVA 58 actinic keratosis 58 postherpetic neuralgia PHN 58 infusion reactions 58 Cutaneous 58 paresthesia 58 Tolerability 58 FOLFIRI 58 pheochromocytoma 58 Asymptomatic 57 mg kg dose 57 Thrombocytopenia 57 Secondary endpoints included 57 overactive bladder OAB 57 COPEGUS 57 mcg kg 57 Urinary tract infections 57 Ischemic

Back to home page